Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I J McGilveray

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
International Journal of Clinical Pharmacology and Biopharmacy|June 1, 1975
Some factors affecting bioavailabilityI J McGilveray
European Journal of Drug Metabolism and Pharmacokinetics|October 14, 2000
Differences in reference products: dissolution and in vivo evidenceI J McGilveray
Canadian Medical Association Journal|October 7, 1978
Theophylline: a factor affecting bioavailabilityI J McGilveray, S Sved
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1991
Harmonization of bioavailability and bioequivalence requirementsI J McGilveray, E Ormsby
Transplantation Proceedings|May 20, 1999
Generic drugs: the Canadian perspectiveI J McGilveray, K Gallicano
Revue Canadienne De Biologie|January 1, 1973
Proceedings: The effect of food intake and sleep on the absorption of acetaminophenG L Mattok, I J McGilveray
Drug Development and Industrial Pharmacy|January 7, 1999
Assessment of pharmaceutical quality of furosemide tablets from multinational marketsS A Qureshi, I J McGilveray
The Journal of Pharmacy and Pharmacology|August 1, 1972
Some factors affecting the absorption of paracetamolI J McGilveray, G L Mattok
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 10, 1998
Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) productS A Qureshi, I J McGilveray
Journal of Pharmaceutical Sciences|May 1, 1972
Comparison of bioavailabilities and dissolution characteristics of commercial tablet formulations of sulfamethizoleG L Mattok, I J McGilveray
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
International Journal of Clinical Pharmacology and Biopharmacy|June 1, 1975
Some factors affecting bioavailabilityI J McGilveray
European Journal of Drug Metabolism and Pharmacokinetics|October 14, 2000
Differences in reference products: dissolution and in vivo evidenceI J McGilveray
Canadian Medical Association Journal|October 7, 1978
Theophylline: a factor affecting bioavailabilityI J McGilveray, S Sved
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1991
Harmonization of bioavailability and bioequivalence requirementsI J McGilveray, E Ormsby
Transplantation Proceedings|May 20, 1999
Generic drugs: the Canadian perspectiveI J McGilveray, K Gallicano
Revue Canadienne De Biologie|January 1, 1973
Proceedings: The effect of food intake and sleep on the absorption of acetaminophenG L Mattok, I J McGilveray
Drug Development and Industrial Pharmacy|January 7, 1999
Assessment of pharmaceutical quality of furosemide tablets from multinational marketsS A Qureshi, I J McGilveray
The Journal of Pharmacy and Pharmacology|August 1, 1972
Some factors affecting the absorption of paracetamolI J McGilveray, G L Mattok
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 10, 1998
Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) productS A Qureshi, I J McGilveray
Journal of Pharmaceutical Sciences|May 1, 1972
Comparison of bioavailabilities and dissolution characteristics of commercial tablet formulations of sulfamethizoleG L Mattok, I J McGilveray
Pageof 10